Funds international teams using multi-omics, genomics, and data integration to improve diagnosis and understanding of rare diseases through innovative interdisciplinary research.
Funder: Canadian Institutes of Health Research
Due Dates: February 12, 2026 (Pre-Proposal to ERDERA) | July 8, 2026 (Full Proposal to ERDERA) | July 9, 2026 (Abbreviated Application to CIHR)
Funding Amounts: Up to CAD 150,000/year for 3 years (max CAD 450,000 per grant); ~3 grants for Canadian teams; total CAD 1,350,000 available.
Summary: Supports international teams to improve diagnosis and understanding of rare diseases through innovative multi-omics, genomics, and data integration approaches.
Key Information: Canadian applicants must submit both to ERDERA and CIHR; only one application as NPA allowed per individual.
This opportunity funds multinational, interdisciplinary research teams focused on improving the diagnosis and understanding of rare genetic and complex non-genetic diseases. The aim is to resolve unsolved cases by identifying causative variants in patients who remain undiagnosed after genetic/genomic testing, and to provide diagnostic clarity for conditions with unknown or mixed pathogenesis. Projects may employ functional validation, multi-omics, advanced bioinformatics, systems biology, and data integration approaches. The program is designed to foster collaborations between Canadian and European researchers, translating research into tangible benefits for rare disease patients.